Abstract: The present invention refers to the cosmetic, pharmaceutical, nutraceutical use of an extract derived from cell cultures of Cannabis sativa, preferably a hydro-alcoholic extract, and a cosmetic, pharmaceutical, nutraceutical composition comprising this extract; in particular, the composition containing this extract of Cannabis sativa may be used to reduce neurogenic inflammation and stimulate the production of neurotransmitters or neuropeptides, such as dopamine and endorphin.
Type:
Application
Filed:
December 16, 2019
Publication date:
March 24, 2022
Applicant:
ARTERRA BIOSCIENCE S.P.A.
Inventors:
Marida Bimonte, Assunta Tortora, Fabio Apone, Maria Gabriella Colucci
Abstract: The present invention relates to a composition with an antioxidant activity, comprising a first dry extract derived from plant cell cultures comprising superoxide dismutase of Sulfolobus solfataricus, a second dry extract derived from plant cell cultures comprising superoxide dismutase of Aeropyrum pernix and a third dry extract derived from plant cell cultures comprising superoxide dismutase from Deinococcus radiodurans, wherein said plant cell cultures are cultures of cells belonging to Solanum lycopersicum species.